This consultation closed on 14 September 2023. The outcome of the consultation was published to the consultation hub on 1 December 2023.
Overview
We conducted a public consultation and sought feedback from interested parties on proposed changes to the requirements of ingredient used in listed medicines. The proposals addressed the following issues:
Curcuma species and curcumin and the risk of liver injury
Green tea extract and the risk of liver injury
Safe levels of benzophenone
Clarification of the requirements for Soy phosphatidylserine-enriched ingredients
Clarification of the requirements for Terminalia ferdinandiana
These ingredients are included in the Therapeutic Goods (Permissible Ingredients) Determination ('the Determination'). This is a legislative instrument made under section 26BB of the Therapeutic Goods Act 1989 ('the Act'). This instrument specifies all of the ingredients that are available for use in listed medicines and the requirements for their use. The Determination is continually reviewed by us to ensure that all ingredients are safe for use in low-risk medicines.
